Magnisense

company

About

Magnisense is a develops emergency diagnostic tests for cardiovascular diseases

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€5M
Industries
Health Care,Health Diagnostics,Medical
Founded date
Jan 1, 2003
Number Of Employee
1 - 10
Operating Status
Active

Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€10.50M
Magnisense has raised a total of €10.50M in funding over 2 rounds. Their latest funding was raised on Oct 26, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 26, 2018 Series Unknown €5M 2 Detail
Nov 27, 2015 Series Unknown €5.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Magnisense is funded by 2 investors. Minv and Concorde Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Minv Series Unknown
Concorde Capital Series Unknown